Venkataraman Shreyas, Vungarala Soumya, Covassin Naima, Somers Virend K
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, NY 55901, USA.
J Clin Med. 2020 Feb 21;9(2):591. doi: 10.3390/jcm9020591.
Sleep apnea is very common in patients with cardiovascular disease, especially in patients with hypertension. Over the last few decades a number of discoveries have helped support a causal relationship between the two and even resistant hypertension. The role neurogenic mechanisms play has gathered more attention in the recent past due to their immediate bedside utility. Several innovative discoveries in pathogenesis including those exploring the role of baroreflex gain, cardiovascular variability, chemoreceptor reflex activation and the sympathetic nervous system have emerged. In this review, we discuss the epidemiology of sleep apnea and hypertension and the pathogenic mechanisms contributing to neurogenic hypertension. Furthermore, recent management strategies in addition to continuous positive airway pressure (CPAP), such as upper airway stimulation and renal denervation that target these pathogenic mechanisms, are also discussed.
睡眠呼吸暂停在心血管疾病患者中非常常见,尤其是在高血压患者中。在过去几十年里,一些发现有助于支持两者之间的因果关系,甚至是顽固性高血压。由于神经源性机制在床边的直接实用性,其在最近受到了更多关注。在发病机制方面有几项创新性发现,包括那些探索压力反射增益、心血管变异性、化学感受器反射激活和交感神经系统作用的发现。在本综述中,我们讨论了睡眠呼吸暂停和高血压的流行病学以及导致神经源性高血压的发病机制。此外,还讨论了除持续气道正压通气(CPAP)之外的近期管理策略,例如针对这些发病机制的上气道刺激和肾去神经支配。